- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x ZKM: N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]-hexadecanamide(Non-covalent)
ZKM.5: 19 residues within 4Å:- Chain A: R.353, M.374, R.396
- Chain B: L.101, I.103, V.105, L.110, R.113, E.115, I.147, F.149, P.150, Y.154
- Chain C: S.429, R.450, F.454, S.455
- Ligands: ZKM.6, ZKM.9
11 PLIP interactions:8 interactions with chain B, 2 interactions with chain A, 1 interactions with chain C- Hydrophobic interactions: B:L.101, B:I.103, B:V.105, B:I.147, B:F.149, B:P.150, B:Y.154, B:Y.154, C:F.454
- Hydrogen bonds: A:M.374
- Salt bridges: A:R.396
ZKM.6: 20 residues within 4Å:- Chain A: K.279, Q.355
- Chain B: I.69, V.86, F.88, L.97, F.99, E.115, L.117, Y.125, F.127, I.140, P.141, F.142, S.143, A.158, L.172, F.174
- Ligands: ZKM.5, ZKM.9
21 PLIP interactions:4 interactions with chain A, 17 interactions with chain B- Hydrogen bonds: A:K.279, A:K.279, A:Q.355, B:S.143, B:S.143
- Water bridges: A:K.279
- Hydrophobic interactions: B:I.69, B:V.86, B:F.88, B:L.97, B:F.99, B:F.99, B:F.99, B:L.117, B:L.117, B:F.127, B:I.140, B:F.142, B:A.158, B:L.172, B:F.174
ZKM.9: 18 residues within 4Å:- Chain B: I.69, S.70, S.71, I.75, L.77, V.84, F.142, F.144, I.147, F.149, C.156, F.174
- Chain C: K.383, S.402, G.403, S.429
- Ligands: ZKM.5, ZKM.6
15 PLIP interactions:12 interactions with chain B, 3 interactions with chain C- Hydrophobic interactions: B:I.69, B:L.77, B:V.84, B:V.84, B:F.142, B:F.144, B:F.144, B:F.144, B:I.147, B:F.149, B:F.174, B:F.174
- Hydrogen bonds: C:S.402, C:S.429
- Salt bridges: C:K.383
ZKM.14: 19 residues within 4Å:- Chain A: S.429, R.450, F.454, S.455
- Chain C: R.353, M.374, R.396
- Chain D: L.101, I.103, V.105, L.110, R.113, E.115, I.147, F.149, P.150, Y.154
- Ligands: ZKM.15, ZKM.18
11 PLIP interactions:8 interactions with chain D, 2 interactions with chain C, 1 interactions with chain A- Hydrophobic interactions: D:L.101, D:I.103, D:V.105, D:I.147, D:F.149, D:P.150, D:Y.154, D:Y.154, A:F.454
- Hydrogen bonds: C:M.374
- Salt bridges: C:R.396
ZKM.15: 20 residues within 4Å:- Chain C: K.279, Q.355
- Chain D: I.69, V.86, F.88, L.97, F.99, E.115, L.117, Y.125, F.127, I.140, P.141, F.142, S.143, A.158, L.172, F.174
- Ligands: ZKM.14, ZKM.18
21 PLIP interactions:4 interactions with chain C, 17 interactions with chain D- Hydrogen bonds: C:K.279, C:K.279, C:Q.355, D:S.143, D:S.143
- Water bridges: C:K.279
- Hydrophobic interactions: D:I.69, D:V.86, D:F.88, D:L.97, D:F.99, D:F.99, D:F.99, D:L.117, D:L.117, D:F.127, D:I.140, D:F.142, D:A.158, D:L.172, D:F.174
ZKM.18: 18 residues within 4Å:- Chain A: K.383, S.402, G.403, S.429
- Chain D: I.69, S.70, S.71, I.75, L.77, V.84, F.142, F.144, I.147, F.149, C.156, F.174
- Ligands: ZKM.14, ZKM.15
15 PLIP interactions:12 interactions with chain D, 3 interactions with chain A- Hydrophobic interactions: D:I.69, D:L.77, D:V.84, D:V.84, D:F.142, D:F.144, D:F.144, D:F.144, D:I.147, D:F.149, D:F.174, D:F.174
- Hydrogen bonds: A:S.402, A:S.429
- Salt bridges: A:K.383
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Su, L. et al., Sulfatides are endogenous ligands for the TLR4-MD-2 complex. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-07-28
- Peptides
- Toll-like receptor 4,Variable lymphocyte receptor B: AC
Lymphocyte antigen 96: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
CD
C
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- hetero-2-2-mer
- Ligands
- 2 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 2 x NAG- NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 8 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 6 x ZKM: N-[(1S,2R,3E)-2-hydroxy-1-{[(3-O-sulfo-beta-D-galactopyranosyl)oxy]methyl}heptadec-3-en-1-yl]-hexadecanamide(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Su, L. et al., Sulfatides are endogenous ligands for the TLR4-MD-2 complex. Proc.Natl.Acad.Sci.USA (2021)
- Release Date
- 2021-07-28
- Peptides
- Toll-like receptor 4,Variable lymphocyte receptor B: AC
Lymphocyte antigen 96: BD - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AC
AB
CD
C